Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2021.10.15
DATE OF BOARD MEETING
2021.10.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2021.09.28
ARTICLES OF ASSOCIATION
2021.09.28
POLL RESULTS OF THE 2021 FIRST EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 2...
2021.09.23
Notification Letter and Request Form to Non-Registered Shareholders
2021.09.23
2021 INTERIM REPORT
2021.09.06
Notification Letter and Request Form to Non-Registered Shareholders
2021.09.06
PROXY FORM FOR THE 2021 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESDA...
2021.09.06
NOTICE OF THE 2021 FIRST EXTRAORDINARY GENERAL MEETING
2021.09.06
CHANGE OF BUSINESS SCOPE AND AMENDMENT OF THE ARTICLES OF ASSOCIATION AND NOTICE...
第一页
上一页
9
10
11
12
13
下一页
最后一页
